Maven Securities’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,700	Closed	-$466K	–	528
2022 Q1	$466K	Buy	+19,700	New	+$466K	0.02%	207
2021 Q1	–	Sell	-90,000	Closed	-$1.81M	–	986
2020 Q4	$1.81M	Buy	+90,000	New	+$1.81M	0.18%	144